-

National Research Corporation Declares Quarterly Dividend

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 11, 2025, to shareholders of record as of the close of business on Friday, March 28, 2025.

For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health’s commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided by its uniquely empathic heritage, NRC Health’s patient-focused approach, unmatched market research, and emphasis on consumer preferences are transforming the healthcare experience, creating strong outcomes for patients and entire healthcare systems. NRC Health is ranked #1 for Healthcare Experience Management in the 2025 Best in KLAS report.

Contacts

Helen Hrdy
Chief Operating Officer
402-475-2525

Industry:

NRC Health

NASDAQ:NRC
Release Versions
English

Contacts

Helen Hrdy
Chief Operating Officer
402-475-2525

More News From NRC Health

Piedmont Names NRC Health as a Strategic Experience Partner to Support Mission-Driven Growth

LINCOLN, Neb. & ATLANTA--(BUSINESS WIRE)--Piedmont, a Georgia-based healthcare system with nationally-ranked clinical programs, has named NRC Health, the leader in healthcare experience management, as its new strategic experience partner to support the organization’s mission-driven growth and commitment to making a positive difference in every life it touches. The enterprise-wide partnership is designed to elevate the patient, family, employee, and consumer experience across Piedmont’s expansiv...

NRC Health Announces Board Authorization of $60 Million Share Repurchase Program

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced that its Board of Directors authorized a stock repurchase program of up to $60 million of the company’s outstanding common stock through March 31, 2028. NRC Health may repurchase shares from time to time in the open market, through privately negotiated transactions and/or other means in compliance with the Securities Exchange Act...

NRC Health Provides Business Update

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced that it has surpassed $152 million in Total Recurring Contract Value (TRCV) as of March 4, 2026, representing an all-time high in the metric for NRC Health. TRCV represents the amount of revenue projected to be recognized over the next 12 months from renewable contracts and is calculated consistent with the definition previously d...
Back to Newsroom